Clinical Trial Update: Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer [Phase 1]

View source ↗

Summary

Phase Ib study of HS-20093 plus HRS-5041 in patients with advanced prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• HRS-5041
• HS-20093

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Advanced Prostate Cancer | Phase 1 | Status: RECRUITING